Physician

Drew Allen Young, MD

According to 2025 Medicare claims, Drew Young, MD (NPI: 1407411093) practices ophthalmology in the Springfield, MO market, with the plurality of this provider's patient population coming from Greene, MO. This provider's primary affiliated billing organization is MATTAX NEU PRATER EYE CENTER, INC. (NPI: 1790745313; TIN: 431842769) and primary practice location at 65804-4278.

Young's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 508 traditional Medicare patients, billed 3,813 HCPCS/CPT codes, and received $573,332 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,265 prescription claims across 332 beneficiaries totaling $65,672 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 17 records totaling $533. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,754 to $65,672. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$287K$573K2023 Medicare payment: $161,535 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $573,332 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023253922$161,535
20245083,813$573,332

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$33K$66K2020 Drug cost: $3,754 (USD; Tot_Drug_Cst)2021 Drug cost: $16,015 (USD; Tot_Drug_Cst)2022 Drug cost: $13,388 (USD; Tot_Drug_Cst)2023 Drug cost: $24,870 (USD; Tot_Drug_Cst)2024 Drug cost: $65,672 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20203138$3,754
202158153$16,015
202241102$13,388
2023148324$24,870
20243321,265$65,672

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye113377$84
92004New patient complete exam of visual system110110$84
92014Established patient complete exam of visual system193194$80
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more225390$56
92134Imaging of retina195508$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost14980$8,573
Prednisolone AcetatePrednisolone Acetate3287,932$7,812
RocklatanNetarsudil Mesylat/Latanoprost11420$4,953
CyclosporineCyclosporine13525$4,660
Ketorolac TromethamineKetorolac Tromethamine962,973$1,943

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.17$533ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Drew Allen Young, MD?

Tedicare shows public-source Medicare data for Drew Allen Young, MD (NPI 1407411093), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Drew Allen Young, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Drew Allen Young, MD?

Drew Allen Young, MD is linked to MATTAX NEU PRATER EYE CENTER, INC. (billing NPI 1790745313) in the available physician profile data.

Does Drew Allen Young, MD have Open Payments data?

Drew Allen Young, MD has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.